VQ-101 restores enzyme lacking in GBA-linked Parkinson’s: Early trial
The experimental oral therapy VQ-101 can successfully restore a critical cellular function in people with a genetic form of…
Articles by Steve Bryson, PhD
Device lets Parkinson’s patients track their own motor symptoms
Stanford University researchers developed a simple, portable device that allows Parkinson’s disease patients to monitor their motor symptoms remotely, in…
Trial testing Parkinson’s disease-modifying therapy hits milestone
Herantis Pharma announced that its Phase 1b clinical trial evaluating the safety and preliminary efficacy of HER-096, a potential…
AI pen analyzes handwriting to spot Parkinson’s with 96% accuracy
A low-cost, self-powered pen with magnetic ink may help detect early signs of Parkinson’s disease by analyzing handwriting. When…
Copper supplementation shows promise in Parkinson’s mice
Copper supplementation that reaches the brain reduces the signs and symptoms of Parkinson’s disease in a mouse model, a…
Changes in gut, mouth bacteria tied to Parkinson’s cognitive decline
Changes in the bacterial communities in the gut and mouth are associated with cognitive impairment in people with Parkinson’s…
Casma to develop CSM-101 as treatment for Parkinson’s
Casma Therapeutics said it will develop CSM-101 as a potential disease-modifying oral treatment for people with Parkinson’s disease and…
Distinct immune responses may detect Parkinson’s before symptoms
People in the presymptomatic stages of Parkinson’s disease have distinct patterns of stimulated immune responses relative to those with…
New insights into motor control in brain may help in Parkinson’s
Switching actions and stopping movements involve two distinct cognitive motor processes, according to a study that combined computer modeling with…
New test for Parkinson’s disease shows 95% accuracy: Study
A newly developed test was able to distinguish — with an accuracy of 95% — between individuals with and without…